Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 81Endometrial Neoplasms 22Ovarian Neoplasms 12Vaginal Neoplasms 11Vulvar Neoplasms 10Neoplasms 8Sarcoma 6Carcinoma, Ovarian Epithelial 5Pelvic Neoplasms 4Fallopian Tube Neoplasms 4Wilms Tumor 3Urinary Bladder Neoplasms 3Testicular Neoplasms 3Prostatic Neoplasms 3Lymphoma, Large B-Cell, Diffuse 3Locally Advanced Cervical Cancer 3Endometrial Clear Cell Adenocarcinoma 3Dendritic Cell Sarcoma, Interdigitating 3Burkitt Lymphoma 3Breast Neoplasms 3Anus Neoplasms 3Uterine Neoplasms 2Teratoma 2Sezary Syndrome 2Sarcoma, Endometrial Stromal 2Recurrence 2Rectal Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pheochromocytoma 2Penile Neoplasms 2

Interventions

Radiotherapy 1Radiation 1Platinum 1Cisplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified × Radiotherapy × Gynecologic × Clear all
NCT04580771 2026-04-15

A Vaccine (PDS0101) and Chemoradiation for the Treatment of Stage IB3-IVA Cervical Cancer, the IMMUNOCERV Trial

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
22 enrolled
Gynecologic

Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified

Data powered by HemOnc (CC BY 4.0) Colophon âš¡